Mechanism of simvastatin-induced K562 Cell apoptosis

Pharmacology

Volumn 84, Issue 4, 2009, Pages 191-195

  Yang, Yong Chang ^a   Xiao, Dai Wen ^a   Liu, Hua ^a   Chuan, Liang Min ^a   Zeng, Ya Li ^b   Zhou, Ding An ^b   Liu, Wen ^b   Xu, Guo Qiang ^b   Huang, Wen Fang ^a  

^a SICHUAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

^b CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; K562 cells; Nitic oxide; Reactive oxygen species; Simvastatin

Indexed keywords

INDUCIBLE NITRIC OXIDE SYNTHASE; MESSENGER RNA; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; SIMVASTATIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CALCIUM CELL LEVEL; CELL PROLIFERATION; CELL STRAIN K 562; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; DRUG MECHANISM; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL;

APOPTOSIS; CALCIUM; CELL PROLIFERATION; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; K562 CELLS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; REACTIVE OXYGEN SPECIES; SIMVASTATIN;

EID: 69549121560     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000235907     Document Type: Article

References (18)

1. Sivaprasad U, Abbas T, Dutta A: Differential efficacy of 3-hydroxy-3-methylglutaryl CoA reductase inhibitors on the cell cycle of prostate cancer cells. Mol Cancer Ther 2006; 5: 2310-2316.
2. Campbell MJ, Esserman LJ, Zhou Y, Shoemaker M, Lobo M, Borman E, et al: Breast cancer growth prevention by statins. Cancer Res 2006; 66: 8707-8714.
3. Sassano A, Katsoulidis E, Antico G, Altman JK, Redig AJ, Minucci S, et al: Suppressive effects of statins on acute promyelocytic leukemia cells. Cancer Res 2007; 67: 4524-4532.
4. Hoque A, Chen H, Xu XC: Statin induces apoptosis and cell growth arrest in prostate cancer cells. Cancer Epidemiol Biomarkers Prev 2008; 17: 88-94.
5. Kaneko R, Tsuji N, Asanuma K, Tanabe H, Kobayashi D, Watanabe N: Survivin downregulation plays a crucial role in 3-hydroxy- 3-methylglutaryl coenzyme A reductase inhibitor- induced apoptosis in cancer. J Biol Chem 2007; 282: 19273-19281.
6. Yang YC, Huang WF, Chuan LM, Xiao DW, Zeng YL, Zhou DA, et al: In vitro and in vivo study of cell growth inhibition of simvastatin on chronic myelogenous leukemia cells. Chemotherapy 2008; 54: 438-446.
7. Paragh G, Kertai P, Kovacs P, Paragh G Jr, Fulop P, Foris G: HMG CoA reductase inhibitor fluvastatin arrests the development of implanted hepatocarcinoma in rats. Anticancer Res 2003; 23: 3949-3954.
8. Gbelcová H, Lenícek M, Zelenka J, Knejzlík Z, Dvoráková G, Zadinová M, et al: Differences in antitumor effects of various statins on human pancreatic cancer. Int J Cancer 2008; 122: 1214-1221.
9. Bessler H, Salman H, Bergman M, Djaldetti M: On the factors modulating the effect of statins on malignant cell proliferation. Cancer Invest 2007; 25: 279-284.
10. Jadeski LC, Chakraborty C, Lala PK: Role of nitric oxide in tumour progression with special reference to a murine breast cancer model. Can J Physiol Pharmacol 2002; 80: 125-135.
11. Kotamraju S, Williams CL, Kalyanaraman B: Statin-induced breast cancer cell death: role of inducible nitric oxide and arginasedependent pathways. Cancer Res 2007; 67: 7386-7394.
12. Mizuno O, Kobayashi S, Hirano K, Nishimura J, Kubo C, Kanaide H: Stimulus-specific alteration of the relationship between cytosolic Ca 2+ transients and nitric oxide production in endothelial cells ex vivo. Br J Pharmacol 2000; 130: 1140-1146.
13. Liantonio A, Giannuzzi V, Cippone V, Camerino GM, Pierno S, Camerino DC: Fluvastatin and atorvastatin affect calcium homeostasis of rat skeletal muscle fibers in vivo and in vitro by impairing the sarcoplasmic reticulum/mitochondria Ca 2+ -release system. J Pharmacol Exp Ther 2007; 321: 626-634.
14. Sacher J, Weigl L, Werner M, Szegedi C, Hohenegger M: Delineation of myotoxicity induced by 3-hydroxy-3-methylglutaryl CoA reductase inhibitors in human skeletal muscle cells. J Pharmacol Exp Ther 2005; 314: 1032-1041.
15. Zhang CY, Wei TT, Ma H, Ding Y, Cheng DY, Hou JW, et al: Reactive oxygen species are involved in nitric oxide-induced apoptosis of neurons. Prog Biochem Biophys 2001; 28: 81.
16. Irani K: Oxidant signaling in vascular cell growth, death, and survival: a review of the roles of reactive oxygen species in smooth muscle and endothelial cell mitogenic and apoptotic signaling. Circ Res 2000; 87: 179-183.
17. Holstein SA, Knapp HR, Clamon GH, Murry DJ, Hohl RJ: Pharmacodynamic effects of high dose lovastatin in subjects with advanced malignancies. Cancer Chemother Pharmacol 2006; 57: 155-164.
18. Le X, Wei D, Huang S, Lancaster JR Jr, Xie K: Nitric oxide synthase II suppresses the growth and metastasis of human cancer regardless of its up-regulation of protumor factors. Proc Natl Acad Sci USA 2005; 102: 8758-8763.